{"entity":{"type":"insider","cik":"0001920553","url":"/insider/0001920553","json_url":"/insider/0001920553.json","name":"Reich Kristian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":9,"first":"2024-02-16","last":"2026-07-29","span_basis":"filed_date"},"name_variants":[{"name":"Reich Kristian","source":"filing","n_filings":9,"first_seen":"2024-02-16","last_seen":"2026-07-29"}],"transactions":[{"id":6074031,"accession":"0001213900-26-082804","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-082804","line_url":"/filing/0001213900-26-082804#line-1","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":22000.0,"total_display":"22,000.00","total_whole":"22,000","shares_owned_after":2711198.0,"shares_owned_after_display":"2,711,198","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-27","filed_date":"2026-07-29","scope":"insider"},{"id":6236550,"accession":"0001213900-26-080869","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-26-080869","line_url":"/filing/0001213900-26-080869#line-2","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2448.0,"shares_display":"2,448","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":48960.0,"total_display":"48,960.00","total_whole":"48,960","shares_owned_after":2712298.0,"shares_owned_after_display":"2,712,298","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-22","filed_date":"2026-07-23","scope":"insider"},{"id":6236546,"accession":"0001213900-26-080869","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-080869","line_url":"/filing/0001213900-26-080869#line-1","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":20.02,"price_display":"20.02","price_state":"stated","total_value":1001000.0,"total_display":"1,001,000.00","total_whole":"1,001,000","shares_owned_after":2714746.0,"shares_owned_after_display":"2,714,746","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-21","filed_date":"2026-07-23","scope":"insider"},{"id":5798874,"accession":"0001213900-26-080133","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-080133","line_url":"/filing/0001213900-26-080133#line-1","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43700.0,"shares_display":"43,700","price_per_share":20.09,"price_display":"20.09","price_state":"stated","total_value":877933.0,"total_display":"877,933.00","total_whole":"877,933","shares_owned_after":2764746.0,"shares_owned_after_display":"2,764,746","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-20","filed_date":"2026-07-21","scope":"insider"},{"id":6155096,"accession":"0001213900-26-079376","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-079376","line_url":"/filing/0001213900-26-079376#line-1","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16105.0,"shares_display":"16,105","price_per_share":20.01,"price_display":"20.01","price_state":"stated","total_value":322261.05,"total_display":"322,261.05","total_whole":"322,261","shares_owned_after":2808446.0,"shares_owned_after_display":"2,808,446","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-15","filed_date":"2026-07-20","scope":"insider"},{"id":5873821,"accession":"0001213900-26-069753","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-26-069753","line_url":"/filing/0001213900-26-069753#line-3","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":19.43,"price_display":"19.43","price_state":"stated","total_value":971500.0,"total_display":"971,500.00","total_whole":"971,500","shares_owned_after":2824551.0,"shares_owned_after_display":"2,824,551","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-17","scope":"insider"},{"id":5873819,"accession":"0001213900-26-069753","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-26-069753","line_url":"/filing/0001213900-26-069753#line-2","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":18.7,"price_display":"18.70","price_state":"stated","total_value":935000.0,"total_display":"935,000.00","total_whole":"935,000","shares_owned_after":2874551.0,"shares_owned_after_display":"2,874,551","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-16","filed_date":"2026-06-17","scope":"insider"},{"id":5873817,"accession":"0001213900-26-069753","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-069753","line_url":"/filing/0001213900-26-069753#line-1","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":18.89,"price_display":"18.89","price_state":"stated","total_value":944500.0,"total_display":"944,500.00","total_whole":"944,500","shares_owned_after":2924551.0,"shares_owned_after_display":"2,924,551","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-17","scope":"insider"},{"id":4674132,"accession":"0001213900-25-120105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-25-120105","line_url":"/filing/0001213900-25-120105#line-2","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72908.0,"shares_display":"72,908","price_per_share":14.43,"price_display":"14.43","price_state":"stated","total_value":1052062.44,"total_display":"1,052,062.44","total_whole":"1,052,062","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-09","filed_date":"2025-12-10","scope":"insider"},{"id":4674128,"accession":"0001213900-25-120105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-120105","line_url":"/filing/0001213900-25-120105#line-1","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":130000.0,"shares_display":"130,000","price_per_share":15.08,"price_display":"15.08","price_state":"stated","total_value":1960400.0,"total_display":"1,960,400.00","total_whole":"1,960,400","shares_owned_after":72908.0,"shares_owned_after_display":"72,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider"},{"id":3171277,"accession":"0001213900-24-018671","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-24-018671","line_url":"/filing/0001213900-24-018671","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":3300000.0,"total_display":"3,300,000.00","total_whole":"3,300,000","shares_owned_after":2925573.0,"shares_owned_after_display":"2,925,573","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-02-29","scope":"insider","n_lines":2},{"id":3171268,"accession":"0001213900-24-018671","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-018671","line_url":"/filing/0001213900-24-018671","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58922.0,"shares_display":"58,922","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":3240710.0,"total_display":"3,240,710.00","total_whole":"3,240,710","shares_owned_after":2957483.0,"shares_owned_after_display":"2,957,483","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-27","filed_date":"2024-02-29","scope":"insider","n_lines":2},{"id":2060315,"accession":"0001213900-24-016240","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-24-016240","line_url":"/filing/0001213900-24-016240","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1078.0,"shares_display":"1,078","price_per_share":55.30472170686456,"price_display":"55.30","price_state":"stated","total_value":59618.49,"total_display":"59,618.49","total_whole":"59,618","shares_owned_after":99502.0,"shares_owned_after_display":"99,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-21","filed_date":"2024-02-22","scope":"insider","n_lines":2},{"id":2060312,"accession":"0001213900-24-016240","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-016240","line_url":"/filing/0001213900-24-016240","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":57.44,"price_display":"57.44","price_state":"stated","total_value":1148800.0,"total_display":"1,148,800.00","total_whole":"1,148,800","shares_owned_after":2987483.0,"shares_owned_after_display":"2,987,483","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-22","scope":"insider","n_lines":2},{"id":2269838,"accession":"0001213900-24-014996","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001213900-24-014996","line_url":"/filing/0001213900-24-014996","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":60.15,"price_display":"60.15","price_state":"stated","total_value":1203000.0,"total_display":"1,203,000.00","total_whole":"1,203,000","shares_owned_after":2997483.0,"shares_owned_after_display":"2,997,483","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-16","scope":"insider","n_lines":2},{"id":2269832,"accession":"0001213900-24-014996","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-24-014996","line_url":"/filing/0001213900-24-014996","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":60.165,"price_display":"60.16","price_state":"stated","total_value":1203300.0,"total_display":"1,203,300.00","total_whole":"1,203,300","shares_owned_after":3007483.0,"shares_owned_after_display":"3,007,483","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-16","scope":"insider","n_lines":2},{"id":2269826,"accession":"0001213900-24-014996","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-014996","line_url":"/filing/0001213900-24-014996","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920553","owner_name":"Reich Kristian","owner_display_name":"Reich Kristian","owner_url":"/insider/0001920553","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":62.425,"price_display":"62.42","price_state":"stated","total_value":1248500.0,"total_display":"1,248,500.00","total_whole":"1,248,500","shares_owned_after":130071.0,"shares_owned_after_display":"130,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-14","filed_date":"2024-02-16","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001821586","name":"MoonLake Immunotherapeutics","url":"/issuer/0001821586","role":"Officer (Chief Scientific Officer)","n_filings":9,"first_seen":"2024-02-16","last_seen":"2026-07-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001920553","retrieved_at":"2026-08-24T18:02:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}